EBIT: Income before interest and taxes.
Guided Therapeutics Inc. (GTHP) had EBIT of $-2.37M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.77M |
|
$-3.35M |
|
$0.20M |
|
$0.57M |
|
$3.14M |
|
$-2.37M |
|
$-0.82M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
|
EBIT |
$-2.37M |
$-2.02M |
|
78.41M |
|
78.41M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$0.60M |
|
$0.02M |
|
$0.72M |
|
$1.32M |
|
$6.64M |
|
$0.04M |
|
$0.69M |
|
$7.33M |
|
$-7.62M |
|
$-6.01M |
|
$-6.01M |
|
86.15M |
|
| Cash Flow Statement Financials | |
$-1.07M |
|
$-0.00M |
|
$0.74M |
|
$0.39M |
|
$0.06M |
|
$-0.33M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-0.01 |
|
-0.37 |
|
74.45% |
|
-309.26% |
|
-309.26% |
|
-263.49% |
|
-416.69% |
|
-436.25% |
|
$-1.07M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
0.44 |
|
191.75 |
|
1.90 |
|
41.92% |
|
53.21% |
|
-241.39% |
|
53.60% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|